NDC 69189-0401

Viread

Tenofovir Disoproxil Fumarate

Viread is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Avera Mckennan Hospital. The primary component is Tenofovir Disoproxil Fumarate.

Product ID69189-0401_c0885491-e882-4237-90f2-60ebf43d72df
NDC69189-0401
Product TypeHuman Prescription Drug
Proprietary NameViread
Generic NameTenofovir Disoproxil Fumarate
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2015-05-18
Marketing CategoryNDA / NDA
Application NumberNDA021356
Labeler NameAvera McKennan Hospital
Substance NameTENOFOVIR DISOPROXIL FUMARATE
Active Ingredient Strength300 mg/1
Pharm ClassesHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 69189-0401-1

1 TABLET, COATED in 1 DOSE PACK (69189-0401-1)
Marketing Start Date2015-05-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69189-0401-1 [69189040101]

Viread TABLET, COATED
Marketing CategoryNDA
Application NumberNDA021356
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-05-18
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
TENOFOVIR DISOPROXIL FUMARATE300 mg/1

OpenFDA Data

SPL SET ID:d3d0b5ef-8226-49d6-ab66-987943413ccc
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 349251
  • 352050

    • Pharmacological Class

    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

    NDC Crossover Matching brand name "Viread" or generic name "Tenofovir Disoproxil Fumarate"

    NDCBrand NameGeneric Name
    50090-0754VireadTENOFOVIR DISOPROXIL FUMARATE
    53808-0810Vireadtenofovir disoproxil fumarate
    61958-0401VireadTENOFOVIR DISOPROXIL FUMARATE
    61958-0403VireadTENOFOVIR DISOPROXIL FUMARATE
    61958-0404VireadTENOFOVIR DISOPROXIL FUMARATE
    61958-0405VireadTENOFOVIR DISOPROXIL FUMARATE
    61958-0406VireadTENOFOVIR DISOPROXIL FUMARATE
    69189-0401VireadViread
    70518-0546VireadViread
    0093-7104Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    16714-820Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    31722-535Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    42291-800Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    42385-901Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    50268-758TENOFOVIR DISOPROXIL FUMARATEtenofovir disoproxil fumarate
    53808-1128TENOFOVIR DISOPROXIL FUMARATEtenofovir disoproxil fumarate
    60505-4666Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    60687-366Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    64380-714TENOFOVIR DISOPROXIL FUMARATEtenofovir disoproxil fumarate
    65862-421Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    65862-818Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate

    Trademark Results [Viread]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VIREAD
    VIREAD
    76079330 2586295 Live/Registered
    Gilead Sciences, Inc.
    2000-06-28
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.